Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene
Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.
Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD
Cell. 2018 Mar 8. pii: S0092-8674(18)30207-1. doi: 10.1016/j.cell.2018.02.033. PubMed Article

Plasmids from Article

ID Plasmid Purpose
109049pXR001: EF1a-CasRx-2A-EGFPCasRx (NLS-RfxCas13d-NLS) with 2A-EGFP for RNA targeting
109050pXR002: EF1a-dCasRx-2A-EGFPCatalytically inactive dCasRx with 2A-EGFP
109053pXR003: CasRx gRNA cloning backbonehU6-driven expression of guide RNAs compatible with CasRx. 5' processed DR followed by BbsI sites for guide cloning.
109054pXR004: CasRx pre-gRNA cloning backbonehU6-driven expression of guide RNAs compatible with CasRx. Contains BbsI sites for guide cloning flanked by 5' and 3' full-length DRs

Antibodies from Article